FIELD: medicine.
SUBSTANCE: invention concerns medicine area, be more specific, to oncology and can be used for revealing of groups of risk of development of relapse and metastasises of mammary gland cancer. Blood sampling from ulnar vein of the sick with mammary gland cancer is made; plasma is allocated from the obtained blood; infra-red spectra of plasma in a range of 1600-1700 cm-1 is taken, calculation of assay absorption coefficient according to the Bouguer law (β, cm-1) is made, the obtained data is compared with the reference data received on the basis of statistical processing of spectra of assays of group of patients and, at value β - 700-900 cm-1 the patient is shifted to the group of risk of development of relapse and metastasises of mammary gland cancer.
EFFECT: method provides obtaining of possibility of revealing of groups of risk of development of relapse and metastasises of mammary gland cancer after the spent radical antitumoral treatment at an early stage.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIAGNOSING RECURRENCES AND METASTASES OF MALIGNANT NEOPLASMS AFTER RADICAL TREATMENT | 2012 |
|
RU2502469C2 |
METHOD FOR PREDICTION OF HAEMATOGENIC METASTASIS IN BREAST CANCER PATIENTS AFTER ANTICANCER TREATMENT | 2010 |
|
RU2436099C1 |
METHOD FOR PREDICTING RELAPSE OF MAMMARY CANCER | 2003 |
|
RU2263319C2 |
METHOD FOR PREOPERATIVE PREDICTION OF THE RISK OF RECURRENCE IN PATIENTS WITH STAGE T1 ENDOMETRIAL CANCER | 2021 |
|
RU2762493C1 |
METHOD FOR PREDICTION OF DEVELOPING METACHRONOUS COLON CANCER | 2010 |
|
RU2447447C1 |
METHOD FOR PREDICTION OF RECURRENCES OF POSTOPERATIVE MENINGIOMAS | 2018 |
|
RU2689795C1 |
METHOD OF PREDICTING THE DEVELOPMENT OF METASTASES IN PATIENTS WITH UNRESECTABLE TRIPLE-NEGATIVE BREAST CANCER | 2023 |
|
RU2802141C1 |
METHOD OF PREDICTING DURATION OF RECURRENCE-FREE PERIOD IN RADICALLY TREATED PATIENTS WITH MAMMARY GLAND CANCER | 2009 |
|
RU2413231C2 |
METHOD FOR PREDICTING THE DURATION OF A RELAPSE-FREE PERIOD IN PATIENTS WITH RESECTABLE THRICE-NEGATIVE BREAST CANCER | 2021 |
|
RU2780922C1 |
METHOD FOR TREATING CANCER | 2004 |
|
RU2271223C2 |
Authors
Dates
2009-04-20—Published
2007-05-28—Filed